GlaxoSmithKline has shipped its antidepressant Paxil CR to U.S.
pharmacies, nearly four months after FDA officials blocked distribution
amid reports of manufacturing problems at plants in Tennessee and
Puerto Rico. Those problems have been identified and fixed, according
to GSK, and distribution is to resume shortly of the diabetes drug
Avandamet, also manufactured in Puerto Rico.

Related Summaries